Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate |
2005-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9437167f0414c89c6bc9e073a752e6ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d4a4d0e889889770d133b9cf8199cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_072ca009b334a5b82339b9fb738f926e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a9a87c30e8216dc07ecd971056809c7 |
publicationDate |
2021-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3056492-B1 |
titleOfInvention |
Meglumine salt and crystalline forms thereof of a drug (delafloxacin) |
priorityDate |
2004-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |